Vaxart + Emergent: In the news

03.23.2020

Original news coverage of Vaxart's agreement with Emergent BioSolutions to manufacture and develop an experimental oral vaccine candidate for the Coronavirus Disease.

Washington Business Journal: Emergent BioSolutions dives into another coronavirus vaccine effort (March 18, 2020)
Technically - Baltimore: Emergent Biosolutions will manufacture Vaxart’s experimental coronavirus vaccine in Baltimore (March 18, 2020)
RTT News: Vaxart Joins With Emergent To Advance Experimental COVID-19 Vaccine (March 18, 2020)
Baltimore Sun: Baltimore scientists to work on third experimental coronavirus vaccine (March 18, 2020)
The Daily Record: Emergent BioSolutions signs 2nd COVID-19 vaccine deal (March 18, 2020)
The Fly: Emergent BioSolutions, Vertex partner to develop oral COVID-19 vaccine (March 18, 2020)
Market Watch: Vaxart: Emergent to manufacture Vaxart's experimental COVID-19 vaccine (March 18, 2020)

Emergent CDMO

COVID-19 Vaxart In The News

03.19.2020

Vaxart AGREEMENT for Experimental Oral Vaccine Candidate for Coronavirus Disease

GAITHERSBURG, Md.,March 18, 2020(GLOBE NEWSWIRE) --Emergent BioSolutions Inc.(NYSE:EBS) announced today that it has entered...

03.19.2020

Novavax agreement for Experimental Vaccine Candidate for Coronavirus Disease

GAITHERSBURG, Md.,March 10, 2020(GLOBE NEWSWIRE) --Emergent BioSolutions Inc.(NYSE:EBS) announced today that it has entered...

06.01.2020

Emergent BioSolutions Joins U.S. Government’s Warp Speed Program in Landmark Public-Private CDMO Partnership for COVID-19 Vaccine Development and Manufacturing

Emergent and HHS expand 2012 CIADM public-private partnership with task order valued at approximately $628 million for rapid...